NuVasive received expanded FDA 510(k) clearance of the TLX™ interbody fusion system, including an expandable 20° cage, use with allogeneic bone graft and use in additional levels of the spine.
Prior to the new clearance, TLX interbodies were available in 15° lordotic options and only indicated for use with allograft. New levels include use in the thoracic spine and at the thoracolumbar junction to treat disc degeneration or degenerative spondylolisthesis at one or two adjacent levels. Finally, use as an adjunct to fusion in multilevel degenerative scoliosis is now also cleared.
TLX can be used with Integrated Global Alignment® (iGA) software for calculation of alignment parameters, pre-operatively.
Source: NuVasive, Inc.
NuVasive received expanded FDA 510(k) clearance of the TLX™ interbody fusion system, including an expandable 20° cage, use with allogeneic bone graft and use in additional levels of the spine.
Prior to the new clearance, TLX interbodies were available in 15° lordotic options and only indicated for use with allograft. New levels include use in...
NuVasive received expanded FDA 510(k) clearance of the TLX™ interbody fusion system, including an expandable 20° cage, use with allogeneic bone graft and use in additional levels of the spine.
Prior to the new clearance, TLX interbodies were available in 15° lordotic options and only indicated for use with allograft. New levels include use in the thoracic spine and at the thoracolumbar junction to treat disc degeneration or degenerative spondylolisthesis at one or two adjacent levels. Finally, use as an adjunct to fusion in multilevel degenerative scoliosis is now also cleared.
TLX can be used with Integrated Global Alignment® (iGA) software for calculation of alignment parameters, pre-operatively.
Source: NuVasive, Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.